Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 9—September 2022
Research

Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan

Yura K. KoComments to Author , Hiroaki Murayama, Lisa Yamasaki, Ryo Kinoshita, Motoi Suzuki, and Hiroshi Nishiura
Author affiliations: National Institute of Infectious Diseases, Tokyo, Japan (Y.K. Ko, R. Kinoshita, M. Suzuki); Tohoku University, Miyagi, Japan (Y.K.Ko); International University of Health and Welfare, Chiba, Japan (H. Murayama); University of Tokyo, Tokyo (L. Yamasaki); Nagasaki University, Nagasaki, Japan (L. Yamasaki); Kyoto University, Kyoto, Japan (H. Nishiura)

Main Article

Figure 3

Comparison of COVID-19 CFR predictions based on indicators of healthcare burden and asymptomatic rate with CFR when jointly estimated with VE, Tokyo, Japan, January 1–August 31, 2021. Shaded areas show 95% credible intervals. A) 30–59; B) 60–69; C) 70–79; D) 80–89; E) >90 years of age. CFR, case-fatality risk; VE, vaccine effectiveness.

Figure 3. Comparison of COVID-19 CFR predictions based on indicators of healthcare burden and asymptomatic rate with CFR when jointly estimated with VE, Tokyo, Japan, January 1–August 31, 2021. Shaded areas show 95% credible intervals. A) 30–59; B) 60–69; C) 70–79; D) 80–89; E) >90 years of age. CFR, case-fatality risk; VE, vaccine effectiveness.

Main Article

Page created: July 12, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external